initiative round and family members to 8 improve health and quality of life outcomes for people affected by brain tumours. Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: From mice to Priority-driven men: biomarker-driven Collaborative Cancer Garvan Institute of classification of pancreatic Cancer $600,000 15/02/2016 36 Darlinghurst 2010 Australia Medical Research cancer to define the Research gemcitabine/ Scheme molecular subtype: ID1100722. Ref: Priority Driven Developing a Collaborative Symptom Index for Cancer University of The University of Cancer Non-muscle Invasive Bladder $233,159 18/02/2016 36 2006 Australia Sydney Sydney Research Cancer: ID1103036 Ref: Scheme Developing a rapid and Priority Driven quantitative telomere length Collaborative Cancer University of test to measure The University of Cancer $48,495 18/02/2016 12 2006 Australia Sydney chemotherapeutic response Sydney Research to telomerase inhibition: Scheme ID1099299 Ref: CA-G1516/20 Priority Driven Collaborative Improving the cure rates of Cancer University of The University of Cancer childhood brain cancer $64,564 18/02/2016 24 2006 Australia Sydney Sydney Research ID1101390 Ref: CA-G1516/22 Scheme Priority Driven Generation and use of novel Collaborative model systems to study Cancer University of The University of Cancer steroid hormone action in the $98,661 18/02/2016 24 2006 Australia Sydney Sydney Research breast: ID1098796 Ref: Scheme Phase II randomised Priority Driven double blind, Collaborative multisite study of Cancer University of The University of Cancer acetazolamide versus $524,365 29/02/2016 36 2006 Australia Sydney Sydney Research placebo for management of Scheme cerebral oedema in recurrent and/or progressive HGG
initiative round 8 and family members to improve health and quality of life outcomes for people affected by brain tumours. Cancer Australia Priority-driven Collaborative Cancer Research Scheme Garvan Institute of Medical Research Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: From mice to men: biomarker-driven classification of pancreatic cancer to define the gemcitabine/ molecular subtype: ID1100722. Ref: $600,000 15/02/2016 36 Darlinghurst 2010 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Sydney Developing a Symptom Index for Non-muscle Invasive Bladder Cancer: ID1103036 Ref: $233,159 18/02/2016 36 The University of Sydney 2006 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Sydney Developing a rapid and quantitative telomere length test to measure chemotherapeutic response to telomerase inhibition: ID1099299 Ref: CA-G1516/20 $48,495 18/02/2016 12 The University of Sydney 2006 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Sydney Improving the cure rates of childhood brain cancer ID1101390 Ref: CA-G1516/22 $64,564 18/02/2016 24 The University of Sydney 2006 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Sydney Generation and use of novel model systems to study steroid hormone action in the breast: ID1098796 Ref: $98,661 18/02/2016 24 The University of Sydney 2006 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Sydney Phase II randomised double blind, multisite study of acetazolamide versus placebo for management of cerebral oedema in recurrent and/or progressive HGG $524,365 29/02/2016 36 The University of Sydney 2006
grants_reporting_20170703_3.docx